Knuff & Co’s Novavax NVAX Stock Holding History

Knuff & Co’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100	Closed	-$7K	–	139
2022 Q1	$7K	Hold	100	–	–	﹤0.01%	134
2021 Q4	$14K	Sell	100 -100	-50%	-$17.2K	﹤0.01%	141
2021 Q3	$41K	Hold	200	–	–	0.02%	121
2021 Q2	$42K	Buy	+200	New	+$36.6K	0.02%	126

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Knuff & Co's NVAX Position: Q2 2022 in Review

Knuff & Co sold out of Novavax (NVAX) in Q2 2022, closing a stake of 100 shares — an estimated $7K sold.

Knuff & Co first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $42K in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Knuff & Co reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Knuff & Co sold 100 Novavax shares in Q2 2022, an estimated $7K.
Knuff & Co first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
Knuff & Co's Novavax position peaked at $42K in Q2 2021.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Knuff & Co's 13F filing for Q2 2022, filed 8 Aug 2022.